{"id":338,"date":"2026-07-23T13:33:46","date_gmt":"2026-07-23T13:33:46","guid":{"rendered":"https:\/\/moizes.adv.br\/blog\/?p=338"},"modified":"2026-07-23T13:45:42","modified_gmt":"2026-07-23T13:45:42","slug":"afinitor-everolimo","status":"publish","type":"post","link":"https:\/\/moizes.adv.br\/blog\/afinitor-everolimo\/","title":{"rendered":"Plano de sa\u00fade negou Afinitor (Everolimo). Entenda como agir a negativa do plano."},"content":{"rendered":"<div class=\"taxonomy-category wp-block-post-terms\"><a href=\"https:\/\/moizes.adv.br\/blog\/category\/blog\/\" rel=\"tag\">Blog<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/category\/direito-da-saude\/\" rel=\"tag\">Direito da Sa\u00fade<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/category\/direito-da-saude\/planos-de-saude\/negativa-de-cobertura\/medicamentos\/\" rel=\"tag\">Medicamentos<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/category\/direito-da-saude\/planos-de-saude\/\" rel=\"tag\">Planos de Sa\u00fade<\/a><\/div>\n\n\n<p class=\"wp-block-paragraph\">O Everolimo \u00e9 antineopl\u00e1sico de cobertura obrigat\u00f3ria pelos planos de sa\u00fade. Veja por que a negativa baseada no rol da ANS \u00e9 abusiva e como garantir seu direito.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O Afinitor, nome comercial do Everolimo (Everolimus), \u00e9 um medicamento antineopl\u00e1sico de uso oral indicado para o tratamento de diferentes tipos de c\u00e2ncer, incluindo c\u00e2ncer de mama avan\u00e7ado, tumores neuroend\u00f3crinos, c\u00e2ncer renal e esclerose tuberosa. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Registrado pela ANVISA e presente no mercado brasileiro desde 2009, o Everolimo \u00e9 prescrito como parte fundamental de protocolos oncol\u00f3gicos reconhecidos. Ainda assim, planos de sa\u00fade negam sua cobertura com frequ\u00eancia, quase sempre invocando a aus\u00eancia no rol da ANS ou a classifica\u00e7\u00e3o como uso <em>off label<\/em>. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Quando h\u00e1 pedido m\u00e9dico, a negativa do plano de sa\u00fade \u00e9 ilegal.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">O que \u00e9 o Everolimo e para que \u00e9 indicado<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">O Everolimo (Afinitor) \u00e9 um inibidor de mTOR, uma prote\u00edna que regula o crescimento e a divis\u00e3o das c\u00e9lulas. Ao bloquear essa prote\u00edna, o medicamento atrapalha a multiplica\u00e7\u00e3o das c\u00e9lulas tumorais e a forma\u00e7\u00e3o dos vasos sangu\u00edneos que alimentam o tumor.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A bula registra indica\u00e7\u00f5es para c\u00e2ncer de mama metast\u00e1tico, tumores neuroend\u00f3crinos avan\u00e7ados do p\u00e2ncreas, do trato gastrointestinal e do pulm\u00e3o, carcinoma de c\u00e9lulas renais e outras condi\u00e7\u00f5es relacionadas \u00e0 esclerose tuberosa. A ANS, por meio da Resolu\u00e7\u00e3o Normativa 338\/2013, incluiu o Everolimus na lista de quimioter\u00e1picos orais com cobertura obrigat\u00f3ria a partir de 2014 para determinadas indica\u00e7\u00f5es. E a Justi\u00e7a entende que o rol da ANS \u00e9 uma lista m\u00ednima de procedimentos com cobertura obrigat\u00f3ria. Ou seja, ele n\u00e3o impede a cobertura de tratamentos que n\u00e3o constam na lista.<\/p>\n\n\n\n<link href=\"https:\/\/fonts.googleapis.com\/css2?family=Cormorant+Garamond:wght@500;600;700&#038;family=Source+Sans+3:wght@400;500;600;700&#038;display=swap\" rel=\"stylesheet\">\n<style>\n#gmc-cta *{box-sizing:border-box;margin:0;padding:0;}\n#gmc-cta{font-family:\"Source Sans 3\",system-ui,Arial,sans-serif;background:#1C2B4A;color:#fff;padding:46px 24px;text-align:center;border-radius:6px;margin:34px 0;}\n#gmc-cta .in{max-width:620px;margin:0 auto;}\n#gmc-cta h2{font-family:\"Cormorant Garamond\",Georgia,serif;font-weight:600;font-size:clamp(26px,4vw,38px);color:#fff;max-width:620px;margin:0 auto;line-height:1.12;letter-spacing:-.01em;}\n#gmc-cta p{color:rgba(255,255,255,.78);margin:16px auto 28px;max-width:480px;line-height:1.6;font-size:16px;}\n#gmc-cta .btn{display:inline-flex;align-items:center;gap:9px;background:#C8A96E;color:#0D1A30;font-size:15px;font-weight:600;padding:14px 24px;border-radius:2px;text-decoration:none;transition:background .2s;}\n#gmc-cta .btn:hover{background:#F0D9A8;}\n#gmc-cta .btn svg{width:17px;height:17px;}\n<\/style>\n<section id=\"gmc-cta\">\n  <div class=\"in\">\n    <h2>Tem um caso parecido com algum desses?<\/h2>\n    <p>Conte o que aconteceu. A avalia\u00e7\u00e3o inicial \u00e9 sem compromisso \u2014 e o prazo do seu direito j\u00e1 est\u00e1 correndo.<\/p>\n    <a class=\"btn\" href=\"https:\/\/wa.me\/5511952218110?text=Ol%C3%A1%2C%20vim%20pelo%20blog%20e%20gostaria%20de%20avaliar%20o%20meu%20caso.\" target=\"_blank\" rel=\"noopener\">\n      <svg viewBox=\"0 0 24 24\" fill=\"currentColor\"><path d=\"M12.04 2C6.58 2 2.13 6.45 2.13 11.91c0 1.75.46 3.45 1.32 4.95L2 22l5.25-1.38c1.45.79 3.08 1.21 4.79 1.21h.01c5.46 0 9.91-4.45 9.91-9.91C21.96 6.45 17.5 2 12.04 2zm5.8 14.04c-.25.7-1.44 1.33-1.99 1.41-.53.08-1.18.11-1.9-.12-.44-.14-1-.32-1.72-.64-3.03-1.31-5-4.36-5.16-4.56-.15-.2-1.23-1.64-1.23-3.12 0-1.49.78-2.22 1.06-2.52.28-.3.61-.38.81-.38.2 0 .41 0 .58.01.19.01.44-.07.69.53.25.6.86 2.09.94 2.24.08.15.13.33.03.53-.1.2-.15.33-.3.5-.15.18-.32.39-.45.53-.15.15-.31.31-.13.61.18.3.79 1.3 1.69 2.11 1.17 1.04 2.15 1.36 2.46 1.51.3.15.48.13.66-.08.18-.2.76-.89.96-1.19.2-.3.41-.25.69-.15.28.1 1.76.83 2.07.98.3.15.5.22.58.35.07.12.07.72-.18 1.42z\"\/><\/svg>\n      Avaliar meu caso\n    <\/a>\n  <\/div>\n<\/section>\n\n\n\n<h2 class=\"wp-block-heading\">Por que o plano nega e por que essa negativa \u00e9 abusiva<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">As operadoras costumam usar dois argumentos para negar o Everolimo: a aus\u00eancia de previs\u00e3o no rol da ANS para aquela indica\u00e7\u00e3o espec\u00edfica ou o uso off label, que \u00e9 a prescri\u00e7\u00e3o para uma finalidade diferente da descrita originalmente na bula. Nenhum dos dois sustenta a negativa quando h\u00e1 indica\u00e7\u00e3o m\u00e9dica fundamentada.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O Superior Tribunal de Justi\u00e7a, nos REsp 1.726.563\/SP e REsp 1.712.163\/SP (<a href=\"https:\/\/scon.stj.jus.br\/jurisprudencia\/externo\/informativo\/?aplicacao=informativo&amp;acao=pesquisar&amp;livre=@CNOT=%27016855%27\" target=\"_blank\" rel=\"noopener\">Tema 990<\/a>, julgados em recursos repetitivos), fixou tese vinculante: depois do registro pela <a href=\"https:\/\/www.gov.br\/anvisa\/pt-br\" target=\"_blank\" rel=\"noopener\">ANVISA<\/a>, a operadora de plano de sa\u00fade n\u00e3o pode recusar o custeio do tratamento com o f\u00e1rmaco indicado pelo m\u00e9dico respons\u00e1vel pelo benefici\u00e1rio.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sobre o uso off label, o STJ j\u00e1 consolidou que \u00e9 abusiva a recusa de cobertura de medicamento registrado na ANVISA e prescrito pelo m\u00e9dico, mesmo quando o uso \u00e9 para indica\u00e7\u00e3o que n\u00e3o consta na bula original. Basta que exista prescri\u00e7\u00e3o m\u00e9dica fundamentada e registro sanit\u00e1rio do produto.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A<a href=\"https:\/\/www.tjsp.jus.br\/Download\/Portal\/Biblioteca\/Biblioteca\/Legislacao\/SumulasTJSP.pdf\" target=\"_blank\" rel=\"noopener\"> S\u00famula 95 do TJSP<\/a> trata especificamente dos quimioter\u00e1picos: havendo expressa indica\u00e7\u00e3o m\u00e9dica, n\u00e3o prevalece a negativa de cobertura do custeio ou fornecimento de medicamentos associados a tratamento quimioter\u00e1pico. A <a href=\"https:\/\/www.tjsp.jus.br\/Download\/Portal\/Biblioteca\/Biblioteca\/Legislacao\/SumulasTJSP.pdf\" target=\"_blank\" rel=\"noopener\">S\u00famula 102<\/a> vai na mesma linha: \u00e9 abusiva a negativa fundada na aus\u00eancia de previs\u00e3o no rol da ANS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O TJSP j\u00e1 decidiu especificamente sobre o Afinitor. O tribunal afirmou que a operadora n\u00e3o pode interferir na indica\u00e7\u00e3o feita pelo m\u00e9dico e que a cobertura \u00e9 devida, conste ou n\u00e3o o medicamento no rol da ANS, seja o uso domiciliar ou hospitalar.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Antineopl\u00e1sico oral: a regra que derruba a principal defesa das operadoras<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Um ponto que gera muita confus\u00e3o \u00e9 o argumento de que &#8220;medicamentos de uso domiciliar n\u00e3o precisam ser cobertos&#8221;. Essa regra n\u00e3o vale para o Everolimo. O STJ pacificou que os antineopl\u00e1sicos orais, ou seja, os quimioter\u00e1picos administrados por via oral, inclusive em casa, s\u00e3o exce\u00e7\u00e3o expressa \u00e0 regra geral que exclui medicamentos domiciliares. A cobertura desses medicamentos \u00e9 obrigat\u00f3ria, n\u00e3o importa onde o paciente tome o rem\u00e9dio.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">O <a href=\"https:\/\/www.planalto.gov.br\/ccivil_03\/leis\/l9656.htm\" target=\"_blank\" rel=\"noopener\">art. 10, VI, da Lei 9.656\/1998<\/a> e a <a href=\"https:\/\/www.ans.gov.br\/component\/legislacao\/?view=legislacao&amp;task=TextoLei&amp;format=raw&amp;id=NDAzMw==\" target=\"_blank\" rel=\"noopener\">Resolu\u00e7\u00e3o Normativa ANS 465\/2021 <\/a>excluem os antineopl\u00e1sicos orais da regra de n\u00e3o cobertura domiciliar. Na pr\u00e1tica, isso significa que o Everolimo, por ser um quimioter\u00e1pico, deve ser coberto mesmo quando administrado em casa.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">O que fazer se o plano negar o Afinitor<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Pe\u00e7a ao oncologista um relat\u00f3rio m\u00e9dico detalhado justificando a indica\u00e7\u00e3o do Everolimo para o seu caso, com o hist\u00f3rico terap\u00eautico e a aus\u00eancia de alternativas eficazes. Depois, formalize o pedido \u00e0 operadora e exija a negativa por escrito, com o motivo espec\u00edfico declarado. Registre tamb\u00e9m uma reclama\u00e7\u00e3o na ANS.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Se houver urg\u00eancia, o que \u00e9 comum em casos oncol\u00f3gicos, vale considerar um pedido de tutela de urg\u00eancia na Justi\u00e7a, com prazo de 48 horas para o fornecimento sob pena de multa di\u00e1ria.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A negativa abusiva que priva o paciente de um tratamento oncol\u00f3gico prescrito pelo m\u00e9dico gera a obriga\u00e7\u00e3o de fornecer o medicamento. E pode ir al\u00e9m: quando o impacto concreto na vida do benefici\u00e1rio fica demonstrado, a situa\u00e7\u00e3o pode configurar dano moral indeniz\u00e1vel.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Leia tamb\u00e9m:<\/strong> <a href=\"https:\/\/moizes.adv.br\/blog\/plano-de-saude-negou-medicamento\/\">Plano de sa\u00fade negou medicamento. Entenda se a negativa foi abusiva<\/a> e <a href=\"https:\/\/moizes.adv.br\/blog\/plano-de-saude-negou-cirurgia\/\">Plano de sa\u00fade negou cirurgia. Isso \u00e9 abusivo! Entenda seus direitos<\/a>.<\/p>\n\n\n<div class=\"taxonomy-post_tag wp-block-post-terms\"><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/antineoplasico-oral\/\" rel=\"tag\">Antineopl\u00e1sico Oral<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/cancer-de-mama\/\" rel=\"tag\">C\u00e2ncer de Mama<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/cancer-renal\/\" rel=\"tag\">C\u00e2ncer Renal<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/everolimo\/\" rel=\"tag\">Everolimo<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/negativa-de-medicamento\/\" rel=\"tag\">Negativa de Medicamento<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/perguntas-frequentes\/\" rel=\"tag\">Perguntas Frequentes<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/tema-990-stj\/\" rel=\"tag\">Tema 990 STJ<\/a><span class=\"wp-block-post-terms__separator\">, <\/span><a href=\"https:\/\/moizes.adv.br\/blog\/tag\/tratamento-oncologico\/\" rel=\"tag\">Tratamento Oncol\u00f3gico<\/a><\/div>\n\n\n<h3 class=\"wp-block-heading\">FAQ: perguntas frequentes sobre Afinitor (Everolimo)<\/h3>\n\n\n\t\t<div class=\"sp-easy-accordion-block sp-eab-regular-accordion alignwide\"\n\t\t\t\t>\n\t\t\t<div class=\"sp-eab-wrapper sp-eab-vertical-accordion sp-eab-7c8a8805539a\">\n\t\t\t\t\t\t\t\t<div class='sp-eab-accordion sp-eab-mode-vertical sp-eab-vertical-one sp-d-flex' data-accordion-settings=\"{&quot;mode&quot;:&quot;vertical&quot;,&quot;activeEvent&quot;:&quot;click&quot;,&quot;defaultAccordionOpen&quot;:&quot;first-item&quot;,&quot;selectedItemOpen&quot;:0,&quot;openMultiItemAtaTime&quot;:false,&quot;scrollToTopOnLoad&quot;:false,&quot;scrollToTopOnClick&quot;:false,&quot;accordionItemToUrl&quot;:false,&quot;animationEffect&quot;:false,&quot;applyAccessibility&quot;:true}\">\n        \t    \t\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-022ba9213251\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tPara que serve o rem\u00e9dio Everolimo (Afinitor)?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">O Everolimo (nome comercial Afinitor) \u00e9 um medicamento oncol\u00f3gico que bloqueia uma prote\u00edna chamada mTOR, respons\u00e1vel por estimular o crescimento e a divis\u00e3o das c\u00e9lulas tumorais. Na pr\u00e1tica, ele \u00e9 usado para tratar c\u00e2ncer de mama avan\u00e7ado com receptor hormonal positivo, tumores neuroend\u00f3crinos do p\u00e2ncreas e do trato gastrointestinal, carcinoma de c\u00e9lulas renais e algumas condi\u00e7\u00f5es ligadas \u00e0 esclerose tuberosa. \u00c9 um comprimido oral, tomado em casa. Isso torna a cobertura pelo plano de sa\u00fade ainda mais importante, porque n\u00e3o h\u00e1 interna\u00e7\u00e3o para justificar o custeio pelo hospital.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-ebd17aabcb5d\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tO Afinitor foi aprovado pela ANVISA?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">Sim. O Everolimo (Afinitor) tem registro sanit\u00e1rio na ANVISA desde 2009 para as indica\u00e7\u00f5es oncol\u00f3gicas. Esse registro \u00e9 justamente o que fundamenta a obriga\u00e7\u00e3o de cobertura pelo plano de sa\u00fade: o STJ fixou no Tema 990 que, depois do registro pela ANVISA, a operadora n\u00e3o pode recusar o custeio do medicamento indicado pelo m\u00e9dico respons\u00e1vel.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-d0cbcc8090e4\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tQual \u00e9 o princ\u00edpio ativo do Afinitor e quem o fabrica?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">O princ\u00edpio ativo \u00e9 o everolimus. O Afinitor \u00e9 fabricado pelo laborat\u00f3rio Novartis. Tamb\u00e9m existem vers\u00f5es gen\u00e9ricas e similares do everolimus aprovadas pela ANVISA, produzidas por outros laborat\u00f3rios. A cobertura pelo plano de sa\u00fade vale para o princ\u00edpio ativo prescrito pelo m\u00e9dico, seja a vers\u00e3o de marca ou a gen\u00e9rica.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-80b5637b6d9b\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tQuanto custa o rem\u00e9dio Everolimo?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">O pre\u00e7o do Afinitor (Everolimo) varia conforme a dosagem e a apresenta\u00e7\u00e3o, mas pode passar de R$ 10.000 por caixa. Para a maioria das fam\u00edlias, pagar do pr\u00f3prio bolso \u00e9 simplesmente invi\u00e1vel. A Novartis mant\u00e9m um Programa de Suporte ao Paciente que pode ajudar em casos espec\u00edficos, mas a principal via de acesso \u00e9 a cobertura pelo plano de sa\u00fade. Quem n\u00e3o tem plano pode buscar o fornecimento pelo SUS, inclusive pela via judicial contra o Estado.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-5dd8f1b09b44\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tO Everolimo tem no SUS?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">O Everolimus pode estar dispon\u00edvel pelo SUS para algumas indica\u00e7\u00f5es por meio do Componente Especializado da Assist\u00eancia Farmac\u00eautica (CEAF). A disponibilidade, por\u00e9m, varia conforme o estado e o protocolo cl\u00ednico aprovado pelo Minist\u00e9rio da Sa\u00fade (PCDT). Para saber se a sua indica\u00e7\u00e3o est\u00e1 contemplada, procure a Secretaria Estadual de Sa\u00fade ou um advogado especializado em sa\u00fade p\u00fablica. Este artigo trata da cobertura por planos de sa\u00fade privados.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-83dcbb0eac33\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tQuais s\u00e3o as alternativas terap\u00eauticas aos medicamentos que atuam na via mTOR?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">O Everolimo pertence \u00e0 classe dos inibidores de mTOR. Outros medicamentos da mesma classe s\u00e3o o Temsirolimo e o Sirolimo, usados em contextos cl\u00ednicos diferentes. Dependendo do tipo de c\u00e2ncer e do hist\u00f3rico de tratamento, o oncologista tamb\u00e9m pode considerar inibidores de CDK4\/6, inibidores de VEGF ou imunoterapia. Quem escolhe a alternativa \u00e9 o m\u00e9dico, com base no perfil cl\u00ednico do paciente. O plano de sa\u00fade n\u00e3o pode substituir esse julgamento por crit\u00e9rios administrativos.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\n\t\t\t<div\n\t\t\t\tid =\"sp-eab-item-4e10c646ce7f\"\n\t\t\t\tclass=\"sp-eab-accordion-item eab-item-05539a\"\n\t\t\t\t\t\t\t>\n\t\t\t\t<div class=\"sp-eab-accordion-item-wrapper\">\n\t\t\t\t\t\t\t\t<h3 class='sp-eab-accordion-heading sp-d-flex sp-align-center eab-heading-05539a'\n\t\t\t\t\t\t>\n\t\t\t\t<span class='sp-eab-accordion-header-wrapper sp-d-flex sp-align-center eab-icon-position-end'>\n\t\t\t\t\t<span class='sp-eab-accordion-header-start sp-d-flex sp-justify-left sp-align-center'>\n\t\t\t\t\t\t<span class='sp-eab-title-subtitle-wrapper sp-d-flex'>\n\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-wrapper sp-d-flex sp-align-center'>\n\t\t\t\t\t\t\t\t<span class='sp-eab-accordion-title-text'>\n\t\t\t\t\t\t\t\t\tO que fazer quando o plano nega um medicamento oncol\u00f3gico de alto custo?\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<span class='sp-eab-accordion-header-end eab-icon-animated'>\n\t\t\t\t\t\t\t\t\t\t\t\t<span class='sp-eab-expand-collapse-icon sp-d-block'>\n\t\t\t\t\t\t\t<i class='sp-eab-expand-icon eab-icon-angle-down-solid'><\/i>\n\t\t\t\t\t\t\t<i class='sp-eab-collapse-icon eab-icon-angle-up-solid'><\/i>\n\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t<\/span>\n\t\t\t<\/h3>\n\t\t\t\t\t\t\t<!-- accordion body -->\n\t\t\t\t\t<div class='sp-eab-accordion-content eab-content-05539a'>\n\t\t\t\t\t\t\t\t\t\t\t\t<div class='sp-eab-accordion-content-wrapper'>\n\t\t\t\t\t\t\t<div class='sp-eab-accordion-body'>\n\t\t\t    \t\t\t\t\n\n<p class=\"wp-block-paragraph\">Pe\u00e7a ao oncologista um relat\u00f3rio detalhado justificando a indica\u00e7\u00e3o do medicamento, com o hist\u00f3rico de tratamentos anteriores e a aus\u00eancia de alternativas. Solicite \u00e0 operadora a negativa por escrito, com o motivo exato declarado, e registre uma reclama\u00e7\u00e3o na ANS (0800 701 9656 ou ans.gov.br). Com urg\u00eancia m\u00e9dica documentada, \u00e9 poss\u00edvel pedir tutela de urg\u00eancia na Justi\u00e7a. Essa decis\u00e3o pode obrigar o plano a fornecer o medicamento em 48 horas, enquanto o processo tramita.<\/p>\n\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Afinitor (Everolimo). O Everolimo \u00e9 antineopl\u00e1sico de cobertura obrigat\u00f3ria pelos planos de sa\u00fade. Veja por que a negativa baseada no rol da ANS \u00e9 abusiva e como garantir seu direito.<\/p>\n","protected":false},"author":1,"featured_media":340,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_thinkrank_schema_form_data":"","_thinkrank_selected_schema_type":"","_thinkrank_additional_schemas":"","_thinkrank_canonical_url":"","_thinkrank_og_title":"","_thinkrank_og_description":"","_thinkrank_og_image":"","_thinkrank_twitter_title":"","_thinkrank_twitter_description":"","_thinkrank_twitter_image":"","_thinkrank_imported_from":"","_thinkrank_focus_keywords":[],"_thinkrank_focus_keyword":"","_thinkrank_robots_meta_enabled":0,"_thinkrank_robots_meta":"","_thinkrank_advanced_robots_meta":"","_thinkrank_primary_category":0,"footnotes":""},"categories":[1,66,69,67],"tags":[43,53,54,40,33,63,47,59],"class_list":["post-338","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-direito-da-saude","category-medicamentos","category-planos-de-saude","tag-antineoplasico-oral","tag-cancer-de-mama","tag-cancer-renal","tag-everolimo","tag-negativa-de-medicamento","tag-perguntas-frequentes","tag-tema-990-stj","tag-tratamento-oncologico"],"_links":{"self":[{"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/posts\/338","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/comments?post=338"}],"version-history":[{"count":5,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/posts\/338\/revisions"}],"predecessor-version":[{"id":353,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/posts\/338\/revisions\/353"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/media\/340"}],"wp:attachment":[{"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/media?parent=338"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/categories?post=338"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/moizes.adv.br\/blog\/wp-json\/wp\/v2\/tags?post=338"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}